Silver nanoparticles modify VEGF signaling pathway and mucus hypersecretion in allergic airway inflammation

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 1329-1343

  Jang, Sunhyae ^a   Park, Ji Won ^b   Cha, Hye Rim ^a   Jung, Sun Young ^a   Lee, Jeong Eun ^a   Jung, Sung Soo ^a   Kim, Ju Ock ^a   Kim, Sun Young ^a   Lee, Choong Sik ^a   Park, Hee Sun ^a  

^a Chungnam National University   (South Korea)

^b Daejeon St Mary's Hospital   (South Korea)

Author keywords

Allergic airway disease; Hypoxia inducible factor 1 and alpha; ; Vascular endothelial growth factor

Indexed keywords

5 CHLORO 3 [(3,5 DIMETHYL 2 PYRROLYL)METHYLENE] 2 INDOLINONE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MUCIN 5AC; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SILVER NANOPARTICLE; SILVERGEN; UNCLASSIFIED DRUG; VASCULOTROPIN; INTERLEUKIN DERIVATIVE; METAL NANOPARTICLE; MUC5AC PROTEIN, MOUSE; SILVER; VASCULOTROPIN A;

ALLERGIC AIRWAY INFLAMMATION; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; FEMALE; HUMAN; HUMAN CELL; MOUSE; MUCUS HYPERSECRETION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RESPIRATORY TRACT ALLERGY; SIGNAL TRANSDUCTION; ANIMAL; BAGG ALBINO MOUSE; BRONCHUS; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CYTOCHEMISTRY; CYTOLOGY; DRUG EFFECT; LUNG; LUNG LAVAGE; METABOLISM; MUCUS; PATHOLOGY; PATHOPHYSIOLOGY; PNEUMONIA; SECRETION; UMBILICAL VEIN ENDOTHELIAL CELL;

MURINAE; MUS;

ANIMALS; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HISTOCYTOCHEMISTRY; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERLEUKINS; LUNG; METAL NANOPARTICLES; MICE; MICE, INBRED BALB C; MUCIN 5AC; MUCUS; PNEUMONIA; SIGNAL TRANSDUCTION; SILVER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84862315735     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S27159     Document Type: Article

References (66)

1. Holgate ST, Lemanske RF Jr, O'Byrne PM, Kakumanu S, Busse WW. Asthma pathogenesis. In: Adkinson NF Jr, Bochner BS, Busse WW, Holgate ST, Lemanske RF Jr, Simons FE, editors. Middleton's Allergy Principles and Practice. 7th ed. Philadelphia, PA: Mosby Elsevier Inc. 2009;2:911.
2. Lee YC, Lee HK. Vascular endothelial growth factor in patients with acute asthma. J Allergy Clin Immunol. 2001;107:1106-1108.
3. McCullagh A, Rosenthal M, Wanner A, et al. The bronchial circulation-worth a closer look: a review of the relationship between the bronchial vasculature and airway inflammation. Pediatr Pulmonol. 2010;45:1-13.
4. Lee CG, Link H, Baluk P, et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med. 2004;10:1095-1103.
5. Voynow JA, Rubin BK. Mucins, mucus, and sputum. Chest. 2009;135:505-512.
6. Williams OW, Sharafkhaneh A, Kim V, Dickey BF, Evans CM. Airway mucus: from production to secretion. Am J Respir Cell Mol Biol. 2006;34:527-536.
7. Kuyper LM, Paré PD, Hogg JC, et al. Characterization of airway plugging in fatal asthma. Am J Med. 2003;115:6-11.
8. Lundblad LK, Thompson-Figueroa J, Allen GB, et al. Airway hyperresponsiveness in allergically inflamed mice: the role of airway closure. Am J Respir Crit Care Med. 2007;175:768-774.
9. Tsuji JS, Maynard AD, Howard PC, et al. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles. Toxicol Sci. 2006;89:42-50.
10. Heger M. Safety of new bacteria-killing coating questioned. April 20, 2008 Available from: http://www.livescience.com/technology/080421-silver-nano.html. Accessed January 4, 2012.
11. El-Sayed MA. Small is different: shape-, size-, and compositiondependent properties of some colloidal semiconductor nanocrystals. Acc Chem Res. 2004;37:326-333.
12. Larguinho M, Baptista PV. Gold and silver nanooparticles for clinical diagnostics-from genomics to proteomics. J Proteomics. 2011. [Epub ahead of print.]
13. Conde J, Doria G, Baptista P. Noble metal nanoparticles applications in cancer. J Drug Deliv. 2011;2012:1-12.
14. Huang B, Zhang J, Hou J, Chen C. Free radical scavenging efficiency of nano-Se in vitro. Free Radic Biol Med. 2003;35:805-813.
15. Kajita M, Hikosaka K, Iitsuka M, Kanayama A, Toshima N, Miyamoto Y. Platinum nanoparticle is a useful scavenger of superoxide anion and hydrogen peroxide. Free Radic Res. 2007;41:615-626.
16. Kim J, Takahashi M, Shimizu T, et al. Effects of a potent antioxidant, platinum nanoparticle, on the lifespan of Caenorhabditis elegans. Mech Ageing Dev. 2008;129:322-331.
17. Varner K, El-Badaway A, Feldhake D, et al. State of the science literature review: everything nanosilver and more. EPA report, EPA/600/ R-10/89, 2010. Available from: http://www.epa.gov/nanoscience/files/ NanoPaper1.pdf. Accessed January 4, 2012.
18. Kalishwaralal K, Banumathi E, Ram Kumar Pandian S, et al. Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells. Colloids Surf B Biointerfaces. 2009;73:51-57.
19. Sun RW, Chen R, Chung NP, Ho CM, Lin CL, Che CM. Silver nanoparticles fabricated in herpes buffer exhibit cytoprotective activities toward HIV-1 infected cells. Chem Commun. 2005;40:5059-5061.
20. Tian J, Wong K, Ho CM, et al. Topical delivery of silver nanoparticles promotes wound healing. Chem Med Chem. 2007;2:129-136.
21. Park HS, Kim KH, Jang S, et al. Attenuation of allergic airway inflammation and hyperresponsiveness in a murine model of asthma by silver nanoparticles. Int J Nanomed. 2010;5:505-515.
22. Cho JY, Miller M, Baek KJ, et al. Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest. 2004;113:551-560.
23. Lee YC, Kwak YG, Song CH. Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J Immunol. 2002;168:3595-3600.
24. Lee KS, Kim SR, Park HS, Jin GY, Lee YC. Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expression. J Allergy Clin Immunol. 2004;114:1093-1099.
25. Zhong XS, Zheng JZ, Reed E, Jiang BH. SU5416 inhibited VEGF and HIF-1alpha expression through the PI3K/AKT/p70S6K1 signaling pathway. Biochem Biophys Res Commun. 2004;324:471-480.
26. Wilhelm SM, Carter C, Tang L, et al. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res. 2004;64:7099-7109.
27. Wilhelm SM, Adnane L, Newell P, Villanueva A, Llovet JM, Lynch M. Preclinical overview of sorafenib, a multikinase inhibitor that targets both RAF and VEGF and PDGF receptor tyrosine kinase signaling. Mol Cancer Ther. 2008;7:3129-3140.
28. Ke Q, Costa M. Hypoxia-inducible factor-1. Mol Pharmacol. 2006;70:1469-1480.
29. Semenza G. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology. 2009;24:97-106.
30. Gariboldi MB, Ravizza R, Monti E. The IGFR1 inhibitor NVPQEW541 disrupts a pro-survival and pro-angiogenic IGF-STAT3-HIF1 pathway in human glioblastoma cells. Biochem Pharmacol. 2010;80:455-462.
31. Hwang AB, Lee SJ. Regulation of life span by mitochondrial respiration: the HIF-1 and ROS connection. Aging. 2011;3:304-310.
32. Jing Y, Ma N, Fan T, et al. Tumor necrosis factor-alpha promotes tumor growth by inducing vascular endothelial growth factor. Cancer Invest. 2011;29:4485-4493.
33. Jung Y, Isaacs JS, Lee S, Trepel J, Liu ZG, Neckers L. Hypoxia inducible factor induction by tumour necrosis factor in normoxic cells requires receptor interacting protein-dependent nuclear factor κB activation. Biochem J. 2003;370:1011-1017.
34. Lee KS, Kim SR, Park SJ, et al. Hydrogen peroxide induces vascular permeability via regulation of vascular endothelial growth factor. Am J Respir Cell Mol Biol. 2006;35:190-197.
35. Lee KS, Park SJ, Kim SR, et al. Phosphoinositide 3-kinase-33inhibitor reduces vascular permeability in a murine model of asthma. J Allergy Clin Immunol. 2006;118:403-409.
36. Deudero JJ, Caramelo C, Castellanos MC, et al. Induction of hypoxiainducible factor 1 alpha gene expression by vascular endothelial growth factor. J Biol Chem. 2008;283:11435-11444.
37. Li YM, Zhou BP, Deng J, Pan Y, Hay N, Hung MC. A hypoxiaindependent hypoxia-inducible factor-1 activation pathway induced by phosphatidylinositol-3 kinase/Akt in HER2 overexpressing cells. Cancer Res. 2005;65:3257-3263.
38. Kim S, Shao MX, Nadel JA. Mucus production, secretion, and clearance. In: Mason RJ, Broaddus VC, Murray JF, Nadel JA, editors. Murray and Nadel's Textbook of Respiratory Medicine. 4th ed. Philadelphia, PA: Elsevier Saunders. 2005;1:330-354.
39. Jeong JH, Jeong YJ, Cho HJ, et al. Ascochlorin inhibits growth factorinduced HIF-1HHactivation and tumor-angiogenesis through the suppression of EGFR/ERK/p70S6K signaling pathway in human cervical carcinoma cells. J Cell Biochem. 2011. [Epub ahead of print.]
40. Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL. HER2 (Neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol. 2001;21:3995-4004.
41. Yu H, Li Q, Kolosov VP, et al. Regulation of cigarette smoke-mediated mucin expression by hypoxia-inducible factor-1mmvia epidermal growth factor receptor-mediated signaling pathways. J Appl Toxicol. 2011. [Epub ahead of print.]
42. Burrows N, Babur M, Resch J, et al. GDC-0941 inhibits metastatic characteristics of thyroid carcinomas by targeting both the phosphoinositide-3 kinase (PI3K) and hypoxia-inducible factor-133(HIF-1() pathways. J Clin Endocrinol Metab. 2011;96(12):E1934-E1943.
43. Takeyama K, Fahy JV, Nadel JA. Relationship of epidermal growth factor receptors to goblet cell production in human bronchi. Am J Respir Crit Care Med. 2001;163:511-516.
44. Amishima M, Munakata M, Nasuhara Y, et al. Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway. Am J Respir Crit Care Med. 1998;157:1907-1912.
45. Polosa R, Puddicombe SM, Krishna MT, et al. Expression of C-ErbB receptors and ligands in the bronchial epithelium of asthmatic subjects. J Allergy Clin Immunol. 2002;109:75-81.
46. Mosca E, Barcella M, Alfieri R, et al. Systems biology of the metabolic network regulated by the Akt pathway. Biotechnol Adv. 2011. [Epub ahead of print.]
47. Somanath PR, Razorenova OV, Chen J, et al. Akt1 in endothelial cell and angiogenesis. Cell Cycle. 2006;5:512-518.
48. Jiang BH, Liu LZ. PI3K/PTEN signaling in angiogenesis and tumorigenesis. Adv Cancer Res. 2009;102:19-65.
49. Lee KS, Kim SR, Park SJ, et al. Mast cells can mediate vascular permeability through regulation of the PI3K-HIF-1alpha-VEGF axis. Am J Respir Crit Care Med. 2008;178:787-797.
50. Young HW, Williams OW, Chandra D, et al. Central role of Muc5ac expression in mucous metaplasia and its regulation by conserved 5e elements. Am J Respir Cell Mol Biol. 2007;37:273-290.
51. Escande F, Porchet N, Bernigaud A, Petitprez D, Auert JP, Buisine MP. The mouse secreted gel-forming mucin gene cluster. Biochem Biophys Acta. 2004;1676:2405-2250.
52. Chen Y, Zhao YH, Kalaslavadi TB, et al. Genome-wide search and identification of a novel gel-forming mucin MUC19/Muc19 in glandular tissues. Am J Respir Cell Mol Biol. 2004;30:155-165.
53. Culp DJ, Latchney LR, Fallon MA, et al. The gene encoding mouse Muc19: CDNA, genomic organization and relationship to Smgc. Physiol Genomics. 2004;19:303-318.
54. Chen Y, Zhao YH, Di YP, We R. Characterization of human mucin 5b gene expression in airway epithelium and the genomic clone of the amino-terminal and 5a-flanking region. Am J Respir Cell Mol Biol. 2001;25:542-553.
55. Evans CM, Koo JS. Airway mucus: the good, the bad, the sticky. Pharmacol Ther. 2009;121:332-348.
56. Groneberg DA, Eynott PR, Oates T, et al. Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung. Respir Med. 2002;96:81-86.
57. Whittaker L, Niu N, Temann UA, et al. Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T Cells and interleukin-9. Am J Respir Cell Mol Biol. 2002;27:593-602.
58. Evans CM, Williams OW, Tuvim MJ, et al. Mucin is produced by clara cells in the proximal airways of antigen-challenged mice. Am J Respir Cell Mol Biol. 2004;31:382-394.
59. Busse PJ, Fahy JV. Airway mucus and the mucociliary system. In: Adkinson NF Jr, Bochner BS, Busse WW, Holgate ST, Lemanske RF Jr, Simons FE, editors. Middleton's Allergy Principles and Practice. 7th ed. Philadelphia, PA: Mosby Elsevier Inc. 2009;1:659-677.
60. Senapati S, Das S, Batra S. Mucin-interacting proteins: from function to therapeutics. Trends Biochem Sci. 2010;35:236-245.
61. Tyner JW, Kim EY, Ide K, et al. Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals. J Clin Invest. 2006;116:309-321.
62. Burgel PR, Lazarus SC, Tam DC, et al. Human eosinophils induce mucin production in airway epithelial cells via epidermal growth factor receptor activation. J Immunol. 2001;167:5948-5954.
63. Shao MX, Nakanaga T, Nadel JA. Cigarette smoke induces MUC5AC mucin overproduction via tumor necrosis factor-alpha-convertingenzyme in human airway epithelial (NCI-H292) cells. Am J Physiol Lung Cell Mol Physiol. 2004;287:L420-L427.
64. Shim JJ, Dabbagh I, Ueki I, et al. IL-13 induces mucin production by stimulating epidermal growth factor receptors and by activating neutrophils. Am J Physiol Lung Cell Mol Physiol. 2001;280:L134-L140.
65. Takeyama K, Jung B, Shim JJ, et al. Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. Am J Physiol Lung Cell Mol Physiol. 2001;280:L165-L172.
66. Agrawal A, Rengarajan S, Adler KB, et al. Inhibition of mucin secretion with MARCKS-related peptide improves airway obstructioin in a mouse model of asthma. J Appl Physiol. 2007;102:399-405.